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« We are guilty of many errors and many faults, but our worst crime is abandoning the 
children, neglecting the foundation of life. Many of the things we need can wait. The child 
cannot. Right now is the time, his bones are being formed, his blood is being made and his 
senses are being developed. To him we cannot answer “tomorrow”. His name is “today”. » 
Gabriela Mistral – Nobel Prize in Literature (1945) 
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ACCURACY AND ADEQUACY OF GROWTH CHARTS TO ASSESS THE 
NUTRITIONAL STATUS OF THE PORTUGUESE CHILD POPULATION. HAS 
THE USE OF THE CDC 2000 GROWTH CURVES AND THE WHO CHILD 
GROWTH STANDARDS ANY PREDICTIVE IMPLICATION? 
 
Abstract 
Objectives: The aim of this study is to compare the CDC 2000 Growth Charts to the new 
recommended WHO Child Growth Standards and by doing so, to determine the accuracy and 
adequacy of the referred growth charts in assessing the nutritional status of the Portuguese child 
population. 
Methods: On June 2010, a total of 487 children and adolescents aged 6-16 years from a private school 
in Oporto were examined; eating habits, daily physical activity, physical performances and a 
standardized physical examination with measurement of standing height and weight were performed. 
All data available on October 2010 were analysed and after exclusion of 33 children and adolescents 
with missing data, 454 children and adolescents remained for the final analysis. 
Results: The difference in the prevalence of overweight children is 3.1 percentage points higher with 
the WHO charts as compared to the CDC charts. This difference remains almost the same (3.0 
percentage points) for adolescents. The prevalence of obesity in children is persistently higher with the 
WHO charts and the difference in the prevalence of obesity remains quite the same regardless of 
gender (2.7 percentage points for girls vs. 2.8 percentage points for boys). When considering the 
adolescent population, the overall prevalence of obesity remains higher on the basis of the WHO 
charts. 
Conclusions: The comparative analysis of Oporto’s population sample demonstrates that the 
prevalence of overweight/obesity varies considerably depending on which growth charts in 
combination with which cut-off values are applied. The CDC 2000 growth charts, as well as the 
IOTF/Cole references tend to underestimate the prevalence of childhood and adolescence overweight 
and obesity when compared to the WHO growth standards, regardless of age and/or gender. 
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Introduction 
Growth and development are innate characteristics of childhood. Growth is the increase in size of a 
child while development is the progressive acquisition of physical, cognitive, linguistic, social and 
emotional attributes. Progress in growth and development is age-related, and several factors, acting 
independently or in combination, influence the rate and pattern of growth and development. These 
factors include biological, pathological, psychological and social factors, such as genetic inheritance, 
sex, race, hormonal maturation, and intrauterine exposure to certain stimuli, chronic or acute diseases, 
feeding practices, child rearing environment as well as the family’s socio-economic status. 
Assessment of health is particularly challenging in childhood and adolescence. The concepts 
underlying health status for children and adolescents are different from those for adults, precisely 
because they are involved in dynamic processes called growth and development. In fact, growth is the 
single most important indicator of health and monitoring growth is fundamental for health evaluation 
in childhood and adolescence as well as a predictive indicator of health status in adulthood.  
Growth charts were developed to provide an objective evaluation of the child growth and health status 
in clinical assessment and epidemiology. They are used as references or standards to screen inadequate 
growth, such as stunting, underweight and wasting or overweight and obesity in children and 
adolescents. So, growth assessment defines the health status as well as the nutritional status, because 
disturbances in health and nutrition, regardless of their aetiology, invariably affect child and 
adolescent growth.
1
 
One can take two types of approaches to develop growth charts: a) a “descriptive approach”, which 
describes how representative samples of children in the entire population grow; and b) a “prescriptive 
approach”, which describes how well-nourished, healthy children who adhere to established feeding 
and health care recommendations should grow.
2
 Descriptive growth charts, for example the CDC 2000 
Growth Charts, provide references and define the growth status of children in an actual population, in 
a particular place and time. Prescriptive growth charts, for example the WHO Child Growth 
Standards, provide standards and define bounds of normal, healthy growth and consequently health 
problems. 
The health, growth and/or nutritional status are usually assessed by anthropometric measurements. 
Anthropometry is a universally applicable, inexpensive, and non-invasive method to assess the 
proportions, size and composition of the human body.
3
 It is the best general proxy measurement of 
human well-being, reflecting dietary inadequacies, infectious diseases and other environmental health 
threats. As a matter of fact, it reflects both health and nutrition, at individual and collective levels, and 
predicts subsequent ill health, functional impairment and/or mortality. 
At least four variables need to be collected: a) age; b) weight; c) height or length; and d) gender. When 
two of these variables are used together they are called an index. Four indexes are commonly used: a) 
weight-for-age; b) height/length-for-age; c) weight-for-height/length; and d) BMI-for-age. 
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When anthropometric measures have been correctly recorded, clinicians and researchers can assess the 
child’s growth or nutritional status by using standardized age- and sex-specific growth references to 
calculate height/length-for-age, weight-for-age, weight-for-height/length and BMI-for-age Z-scores or 
percentiles. The Z-score system expresses anthropometric values as several standard deviations (SDs) 
below or above the reference mean or median value.
4
 Z-scores and percentiles are equivalent units of 
measurement, because any percentile can be converted to a Z-score and any Z-score can be converted 
into a percentile.  
Malnutrition describes deficiencies, excesses or imbalances in energy, protein or other nutrients’ 
intake.
5
 It is regarded as one of the most serious and challenging problems in public health worldwide. 
The prevalence of under-nutrition remains pervasive, particularly among infants and young children in 
several developing countries. On the other hand, there is a rapid increase in childhood overweight and 
obesity in both developed and developing countries, although in different speeds and in different 
patterns.
6
 Societies enter different stages of what is called the nutrition transition, predominantly 
caused by rapid urbanization and globalization of the human diet. Globally, malnutrition continues to 
affect many populations, with adverse effects on health, mortality, and productivity as well as in terms 
of health status later in adult life. We assist to a pattern of disease shift away from infectious and 
nutrient deficiency diseases toward higher rates of non-insulin-dependent diabetes, coronary heart 
disease and some types of cancer. Thus, preventing malnutrition is of the outmost importance. The 
decision as to whether to intervene requires an accurate identification of children at high risk and this 
is what the growth charts are for.  
Portugal followed developed/western countries’ trend because of the shifting of lifestyles towards 
more sedentary and urban living, and demonstrated a dramatic rise in childhood overweight and 
obesity over the last two decades. In 2008-2009, a study was undertaken by the Portuguese Society for 
the Study of Obesity (SPEO) to determine the prevalence of overweight and obesity among the 
Portuguese child and adolescent population. In the total sample and using the CDC growth charts and 
cut-offs, 16.5% of overweight (85
th
 percentile≤ BMI <95th percentile) and 12.5% of obese (BMI ≥95th 
percentile) children aged 2-5 years as well as 16.9% of overweight and 11.3% of obese adolescents 
11-15 years old were reported. Simultaneously, the WHO – European Childhood Obesity Surveillance 
Initiative (COSI – Portugal) equally using the CDC criteria, estimated the prevalence of overweight 
children aged 6-10 years to be 18.1%. In the same sample of children, the prevalence of obesity was 
13.9%. In fact, the overall prevalence of excess weight in young children 6-10 years old was reported 
to be 32% in Portugal.
7
 Considering the increasing prevalence and importance of overweight and 
obesity among the Portuguese child population, this study will exclusively focus on the accurate 
identification of overweight and obese children and adolescents. 
Which definitions should be used to distinguish obese children, and which definitions are appropriate 
for clinical practice and epidemiology? 
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Obesity is, by definition, an abnormal or excessive body fat accumulation that presents a risk to 
health.
8
 Its assessment should ideally be based on measurement of body fat, such as body fat 
percentage or body fat mass. Measurement of adiposity in children and adolescents can use a range of 
methods, both direct and indirect. Direct techniques for body composition assessment include 
hidrodensitometry, magnetic resonance imaging (MRI), computerized tomography (CT) and dual-
energy X-ray absorptiometry (DEXA). Bioelectrical impedance analysis (BIA) and air-displacement 
plethysmography are both indirect methods based on the relation between body volume, height and 
electrical impedance and between body volume, mass and densities, respectively. Nevertheless, 
measurements of body fatness are rarely possible in clinical practice and frequently unsuitable for 
epidemiological work. Therefore, simpler and reproducible measurements of body fatness are 
preferred. Anthropometric measures of relative adiposity, such as waist, hip and other girth 
measurements, skinfold thickness and indexes derived from measured height and weight, such as the 
body mass index [BMI = weight (kg)/height² (m²)] are commonly used.
9
 BMI is a simple and 
convenient proxy measure of adiposity which is now widely recommended for paediatric use.
10
 It has 
a high specificity (95-100%), and so will identify few non-obese children as obese. On the other hand, 
it has a low sensitivity (36-66%), which is a problem in terms of epidemiological work, as it will 
considerably underestimate the prevalence of obesity. A further limitation of BMI is its inadequacy to 
discern trends in obesity. When BMI increases in populations over time changes in lean body mass 
cannot be readily distinguished from changes in body fatness.
11, 12
 
Obesity definitions in childhood which use BMI rely on cut-off values relative to age- and sex-specific 
growth references. The limitations of BMI can be minimized in children by choosing the most 
adequate growth references and cut-off values. The question is: which growth references and cut-off 
points are the most adequate and reliable for clinical practice and epidemiology? 
The CDC 2000 Growth Charts have their origin in the charts published by the National Centre for 
Health Statistics (NCHS) in 1977. These original charts were based on data from the Fels Longitudinal 
Growth Study as well as from nationally representative surveys. However, they showed some flaws 
that motivated their revision in 1978 and in 2000 by the Centres for Disease Control and Prevention 
(CDC). The main concern centred on the Fels Research Institute data used to develop the children 
charts. The data were not representative of the entire country; there was a lack of racial diversity; the 
infants included were primarily formula fed; and there was a large disjunction in length and height 
measurements between the infant and older child growth curves between 24 and 36 months of age.
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The CDC charts for the United States were based on cross-sectional data from various sources: 
National Vital Statistics (birth weights); Missouri and Wisconsin Vital Statistics (birth lengths); 
Paediatric Nutrition Surveillance System (lengths); NHANES I (1971-1974); NHANES II (1976-
1980); and NHANES III (1988-1994).
14
 The curves for children aged 2-59 months were primarily 
based on data from NHANES (i.e. a continuous cross-sectional survey of the health and nutritional 
status of US civilian, non-institutionalized population). However, no NHANES data were available for 
5 
 
infants aged <2 months, so emerged the need to add younger-aged infants data from other sources, 
namely from the CDC Paediatric Nutrition Surveillance System (PedNSS). The CDC growth charts 
excluded very low birth weight infants (<1500g) but had no inclusion or exclusion criteria related to 
feeding or environmental variables. No overweight measurements were excluded. 
As a matter of fact, during the last thirty years (1978-2006), the World Health Organization (WHO) 
adopted the NCHS/CDC charts as an international reference and recommended their use to assess 
growth and health status among children and adolescents worldwide. 
In 1997, the World Health Organization launched the Multicentre Growth Reference Study (MGRS) to 
collect data on the growth of children worldwide based on strict inclusion and exclusion criteria. Data 
collection was completed in 2003 and the charts were released in 2006.  
The 2006 WHO Growth Curves for children under 5 years of age are based on the data collected in six 
sites: Pelotas, Brazil; Accra, Ghana; Delhi, India; Oslo, Norway; Muscat, Oman; and Davis-California, 
USA. The study has two components: a) a longitudinal component of children aged 0-24 months; and 
b) a cross-sectional component of children aged 18-71 months. The criteria for inclusion in the MGRS 
were: a) socioeconomic status that does not constrain growth of the child; b) low enough population 
mobility to allow for 2-years follow-up; c) at least 20% of mothers in the community willing to follow 
international feeding recommendations, namely d) exclusive breastfeeding for at least 4 months; e) 
introduction of complementary foods by at least 6 months but not before 4 months; and f) continued 
breastfeeding for at least 12 months. The exclusion criteria were: a) maternal smoking during 
pregnancy or lactation; b) birth at <37 weeks or >42 weeks; c) multiple birth; and d) substantial 
morbidity. Weight-for-height >3 SDs from the overall study median were considered to be outliers and 
excluded from the final sample.
14
 
The WHO growth standards are based on the confirmed hypothesis (i.e. the mean length measurement 
of children aged <24 months in the six country sites were virtually identical) that all children have the 
potential to grow similarly, regardless of their ethnic group or place of birth, if they are in a healthy 
environment and receive adequate nutrition and health care.  
Experts rapidly agreed that an appropriate single growth reference for the screening, monitoring and 
surveillance of school-aged children and adolescents was needed. They also agreed that a multicentre 
study, identical to the one developed for the 2006 WHO Child Growth Standards, would not be 
possible for older children, because it would not be possible to control the dynamics of their 
environment. As an alternative, a growth reference was developed. The WHO reconstructed the 1977 
NCHS/WHO growth reference using the original sample, supplemented with data from the 2006 
WHO Child Growth Standards, and applying the state-of-the-art statistical methods used to develop 
the standards for preschool children. In 2007, the WHO Growth Reference for school-aged children 
and adolescents 5 to 19 years old was published based on three data sets: a) Health Examination 
Survey (HES) Cycle II (6-11 years); b) HES Cycle III (12-17 years); and c) Health and Nutrition 
Examination Survey (HANES) Cycle I (1-24 years). The 2007 WHO Growth References are almost 
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perfectly aligned with the 2006 WHO Child Growth Standards at 5 years and at 19 years of age, the 
2007 BMI values for both sexes at +1 and +2 SD values (25.4 kg/m² for boys; 25.0 kg/m² for girls and 
29.7 kg/m² for both sexes, respectively) are equivalent to the overweight and obesity cut-offs used for 
adults (≥25.0 kg/m² and ≥30.0 kg/m², respectively).15  
Reference sets of charts, such as the 2000 CDC Growth Charts and the WHO Growth Standards are 
intended for clinical use in monitoring children’s growth. They are not specifically intended to define 
overweight and obesity. There are a number of sets of BMI reference data, such as the IOTF/Cole 
references that are specifically conceived to define childhood overweight and obesity and these 
include specific cut-off values.
16
 
Wang Y. and Wang J. Q.
17
 in 2002 compared the three major international reference sets of BMI 
values used to assess child and adolescent overweight and obesity: a) The Must, Dallal and Dietz 
(MDD) references, based on data from the US NHANES I collected in 1971-1974, which recommend 
the sex-specific smoothed 85
th
 and 95
th
 percentiles to classify child/adolescent overweight and obesity, 
respectively. These cut-off values are still used in many countries, inclusive in Portugal through the 
CDC 2000 Growth Charts. b) The IOTF/Cole references, with sex-age-specific BMI cut-off points 
developed from sex-specific BMI-age curves based on six nationally representative data sets from 
Brazil, UK, Hong Kong, the Netherlands, Singapore and the USA, that pass through a BMI of 25.0 
kg/m² for overweight and 30.0 kg/m² for obesity at age 18 years. The latter are adult BMI cut-offs, 
which are good indicators of risk of adverse health outcomes. c) The WHO references, which use the 
weight-for-height Z-score +2 SD (which corresponds to the 97.7
th
 percentile) to classify children under 
10 years of age as overweight. They do not provide a reference for obesity for children of the same age 
group. The sex-age-specific BMI 85
th
 percentile developed by Must et al. and both the same BMI 85th 
percentile and triceps skinfold thickness 90
th
 percentile are used to classify adolescents (10-19 years) 
as overweight and obese, respectively. Wang et al. showed that the IOTF, MDD and WHO references 
produce similar estimates for the overall combined prevalence of overweight and obesity. However, 
the WHO references produce slightly higher estimates for children and lower estimates for adolescents 
than the IOTF references. 
Nowadays, the WHO suggests in its training course on assessment of child growth the Z-scores +1, +2 
and +3 SDs as cut-off points for defining children as at risk of overweight, overweight and obese, 
respectively.
18
 
Each reference has its own limitations; one should be aware of those limitations and should be 
cautious when comparing results based on different references. Considering the simplicity of use and 
the relationship with BMI cut-off values used for adults (which avoids some arbitrariness of choosing 
reference cut-offs), the IOTF/Cole references seem to be slightly superior.
12, 19, 20
 Nevertheless, the 
IOTF/Cole cut-off values have not been endorsed at national level for clinical use in monitoring 
children’s growth, but they are largely recommended for international comparisons of prevalence of 
overweight and obesity.
19
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Material and methods 
In 2010, FADEUP (Faculdade de Desporto da Universidade do Porto) initiated an intervention 
program to promote healthy lifestyle habits among the Portuguese school-aged population. In a first 
approach, all children and adolescents aged 6-16 years from a private school in Oporto were included 
in this program. The FADEUP team examined, on June 2010, a total of 487 children and adolescents 
as they attended their sports classes and were lightly dressed; the FADEUP team undertook a person 
by person interview to assess eating habits and daily physical activity followed by an overall 
evaluation of their physical performances and a standardized physical examination with measurement 
of standing height and weight as well as a bioelectrical impedance analysis. 
For the purpose of this study, all data available on October 2010 were analysed and after exclusion of 
33 children and adolescents with missing data namely birth date, gender specification or height and/or 
weight measurements, 454 children and adolescents remained for the final analysis.  
Three sets of cut-off values were used to define overweight and obesity. Overweight was defined as 
BMI-for-age ≥85th percentile and <95th percentile (CDC) or ≥85th percentile and <97th percentile 
(WHO) or ≥25.0 kg/m² and <30.0 kg/m² at age 18 (IOTF/Cole). Obesity was defined as BMI-for-age 
≥95th percentile (CDC) or ≥97th percentile (WHO) or ≥30.0 kg/m² at age 18 (IOTF/Cole). The WHO 
recommendations (Z-score +2SD≤ BMI <+3SD to define overweight and Z-score BMI ≥+3SD to 
define obesity) were expressed as the corresponding percentile definitions to put the 3 sets of cut-off 
values on a common basis.  
All data were analysed with Nut Stat (Epi Info version 3.5.3) software of the CDC and Anthro Plus 
version 1.0.4 of the WHO to calculate percentiles and Z-scores for the sex-specific CDC 2000 and the 
WHO 2006/2007 references, respectively. To establish an IOTF/Cole references-based analysis of the 
data collected, international cut-off points for BMI for overweight and obesity by sex between 2 and 
18 years published by Cole et al.
19
 were used. The data obtained were further statistically treated with 
Microsoft© Excel 2010 software. All prevalence estimates and 95% confidence intervals (95% CI) 
were summarized in 2 age groups, ≤11 years (n=253) and >11 years (n=201), as children and 
adolescents, respectively. 
 
Results 
Shown in Figures 1-4 and Table 1 are comparisons of the overall prevalence of overweight and obesity 
for Oporto’s population sample of children and adolescents aged 6-16 years (Fig. 1 and 3), as well as 
the prevalence of overweight and obesity for the same population stratified by sex (Fig. 2 and 4) on 
the basis of the CDC 2000, the WHO 2006/2007 and the IOTF/Cole growth charts. All comparisons 
are made according to the biologic age, i.e. according to age groups ≤11years and >11 years.  
When we compare the prevalence of overweight in children (≤11 years), the difference in the 
prevalence of overweight is 3.1 percentage points higher with the WHO charts as compared to the 
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CDC charts. This difference remains almost the same (3.0 percentage points) for adolescents (>11 
years) (Fig. 1). The prevalence of overweight stratified by sex among children remains higher on the 
basis of the WHO charts and the difference in the prevalence of overweight is higher among boys (2.7 
percentage points for girls vs. 3.5 percentage points for boys) (Fig. 2). However, when considering the 
sex-specific prevalence of overweight among adolescents, this varies considerably. In fact, the 
prevalence of overweight in boys >11 years old is higher on the basis of the CDC charts than on the 
basis of the WHO charts (Fig. 2B). 
 
 
Figure 1 Comparison of the prevalence of overweight (BMI-for-age) based on the CDC 2000 and the WHO 2006/2007 
growth charts and on the IOTF/Cole references for Oporto’s population sample of children (≤11 years) and adolescents (>11 
years), respectively. 
 
  
Figure 2 Comparison of the prevalence of overweight (BMI-for-age) based on the CDC 2000 and the WHO 2006/2007 
growth charts and on the IOTF/Cole references for Oporto’s population sample of girls (Panel A) and boys (Panel B) ≤11 
years and >11 years, respectively. 
 
A B 
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The prevalence of obesity in children is persistently higher with the WHO charts and the difference in 
the prevalence of obesity remains quite the same regardless of gender (2.7 percentage points for girls 
vs. 2.8 percentage points for boys) (Fig. 4). When considering the adolescent population, the overall 
prevalence of obesity remains higher on the basis of the WHO charts (Fig. 3). However, there is no 
difference in the prevalence of obesity among girls (Fig. 4A) and the difference in the prevalence of 
obesity among boys is 2.7 percentage points higher with the WHO charts (Fig. 4B). 
 
 
Figure 3 Comparison of the prevalence of obesity (BMI-for-age) based on the CDC 2000 and the WHO 2006/2007 growth 
charts and on the IOTF/Cole references for Oporto’s population sample of children (≤11 years) and adolescents (>11 years), 
respectively. 
 
  
Figure 4 Comparison of the prevalence of obesity (BMI-for-age) based on the CDC 2000 and the WHO 2006/2007 growth 
charts and on the IOTF/Cole references for Oporto’s population sample of girls (Panel A) and boys (Panel B) ≤11 years and 
>11 years, respectively. 
 
A B 
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The same phenomenon is observed when the WHO 2006/2007 growth charts are compared to the 
IOTF/Cole references. The overall prevalence of overweight and obesity is persistently higher on the 
basis of the WHO charts, regardless of age and gender (Fig. 1-4). There is, however, one exception. 
The prevalence of overweight in boys aged >11 years is higher on the basis of the IOTF/Cole 
references than on the basis of the WHO charts, the difference in the prevalence of overweight being 
6.4 percentage points higher with the IOTF/Cole references (Fig. 2B). 
 
PREVALENCE OF CHILDHOOD AND ADOLESCENCE OVERWEIGHT AND OBESITY FOR OPORTO’S 
POPULATION SAMPLE 
  OVERWEIGHT PREVALENCE (%) 
[BMI-for-age] (95% CI) 
OBESITY PREVALENCE (%) 
[BMI-for-age] (95% CI) 
    
 Charts Overall Girls Boys Overall Girls Boys 
        
Children 
(≤11 years) 
       
 CDC 12,3 
(9,2-15,3) 
12,5 
(9,5-15,5) 
12,1 
(9,1-15,1) 
3,6 
(1,9-5,3) 
0,0 
(0,0-0,0) 
6,4 
(4,1-8,6) 
        
 WHO 15,4 
(12,1-18,7) 
15,2 
(11,9-18,5) 
15,6 
(12,3-18,9) 
6,3 
(4,1-8,6) 
2,7 
(1,2-4,2) 
9,2 
(6,6-11,9) 
        
 IOTF/Cole 12,6 
(9,6-15,7) 
11,6 
(8,7-14,6) 
13,5 
(10,3-16,6) 
1,6 
(0,4-2,7) 
0,0 
(0,0-0,0) 
2,8 
(1,3-4,4) 
        
Adolescents 
(>11 years) 
 
 CDC 12,9 
(9,8-16,0) 
7,7 
(5,2-10,1) 
17,3 
(13,8-20,7) 
5,5 
(3,4-7,6) 
2,2 
(0,8-3,5) 
8,2 
(5,7-10,7) 
        
 WHO 15,9 
(12,6-19,3) 
17,6 
(14,1-21,1) 
14,5 
(11,3-17,8) 
7,0 
(4,6-9,3) 
2,2 
(0,8-3,5) 
10,9 
(8,0-13,8) 
        
 IOTF/Cole 15,4 
(12,1-18,7) 
8,8 
(6,2- 11,4) 
20,9 
(17,2-24,6) 
2,5 
(1,1-3,9) 
1,1 
(0,1-2,1) 
3,6 
(1,9-5,4) 
 
Table 1 Comparison of the estimated overall and by sex prevalence of overweight and obesity in Oporto’s population sample 
of children and adolescents aged 6-16 years, using the CDC 2000 and the WHO 2006/2007 growth charts, as well as the 
IOTF/Cole references. 95% confidence intervals are in parenthesis. 
 
Figures 5 and 6 show the growth patterns in childhood and adolescence for the Portuguese school-
aged population under study. Mean BMI-for-age Z-scores of Oporto’s population sample of children 
and adolescents aged 6-16 years are drawn relative to the CDC and the WHO growth references 
according to gender. 
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Figure 5 Mean BMI-for-age Z-score of Oporto’s population sample of girls aged 6-16 years relative to the CDC and to the 
WHO growth references. 
 
Figure 6 Mean BMI-for-age Z-score of Oporto’s population sample of boys aged 6-16 years relative to the CDC and to the 
WHO growth references. 
 
The simple linear regression model finds the best-fit line that goes near data points. More precisely, 
the linear regression model finds the line that minimizes the sum of the squares of the vertical 
distances of the data points from the line. Figure 7 shows the application of this model to Oporto’s 
overall population of children and adolescents aged 6-16 years and consequently the best-fit regression 
lines for the mean BMI-for-age Z-scores were obtained.  
 
A 
12 
 
 
Figure 7 Linear regression of the mean BMI-for-age Z-score for Oporto's overall population sample of children and 
adolescents aged 6-16 years based on the CDC (Panel A) and WHO growth references (Panel B), respectively. 
 
Nonlinear regression, in contrast to linear regression, enables to fit curves by adjusting data points in 
small steps to improve the goodness of fit. The polynomial regression is special because it is not a 
strictly nonlinear regression and thus overcomes some of the flaws of nonlinear regression. As shown 
in Figures 8 and 9, the polynomial regression (third-order) was applied to the mean BMI-for-age Z-
score of Oporto’s population sample of children and adolescents aged 6-16 years according to their 
gender and based on the CDC and WHO growth references.  
 
 
Figure 8 Polynomial regression of the third-order of BMI-for-age Z-score for Oporto's population sample of girls aged 6-16 
years based on the CDC (Panel A) and WHO growth references (Panel B), respectively. 
B 
A 
B 
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Figure 9 Polynomial regression of the third-order of the mean BMI-for-age Z-score for Oporto's population sample of boys 
aged 6-16 years based on the CDC (Panel A) and WHO growth references (Panel B), respectively. 
  
 
Figure 10 Mean BMI-for-age of Oporto's population sample of children and adolescents aged 6-16 years separated by gender 
and traced relative to the 50th percentiles of the CDC 2000 and WHO 2006/2007 growth charts. 
 
 
Girls Boys 
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14 
 
Discussion 
The comparative analysis of Oporto’s population sample of children and adolescents aged 6-16 years 
demonstrates that the prevalence of overweight and obesity varies considerably depending on which 
growth charts in combination with which cut-off values are applied. The CDC 2000 growth charts, as 
well as the IOTF/Cole references tend to underestimate the prevalence of childhood and adolescence 
overweight and obesity when compared to the WHO 2006/2007 growth standards, regardless of age 
and/or gender. 
When considering infants and pre-school children (0-5 years old), this is not surprising. In fact, the 
WHO and the CDC growth charts are based on different methodological approaches for data 
collection and data analysis. The CDC 2000 growth charts took a descriptive approach to generate a 
reference that describes how children grew between the 1960s and the early 1990s in the United 
States. On the other hand, the WHO 2006 growth standards took a prescriptive approach with the goal 
of generating a standard to describe how children all over the world should grow. In the descriptive 
approach of the CDC, and in contrast to the prescriptive approach of the WHO, no selection of 
children was made to ensure that they were healthy, receiving adequate health care, or being fed 
appropriately (breast-fed), and thus children with unhealthy growth, predominantly overweight and 
obese children, were included in the CDC reference. As a matter of fact, the CDC growth charts have 
proven to be inadequate for assessing and monitoring the growth of breast-fed infants.
21 
What about school-aged children and adolescents? Are the CDC growth charts, compared to the WHO 
charts, equally inadequate in assessing and monitoring their growth and nutritional status?  
Currently, most populations in developed as well as developing countries tend to demonstrate a 
secular trend towards overweight and obesity. It is widely recognized that using descriptive samples of 
those populations to construct growth references results inevitably in an inaccurate upward skewness 
leading to an underestimation of overweight and obesity and an overestimation of under-nutrition. In 
consequence, the WHO developed a growth reference (not a growth standard) for children and 
adolescents aged 5 to 19 years by reconstructing the 1977 NCHS/WHO growth reference using the 
original sample - a non-obese sample with expected heights, supplemented with data from the 2006 
WHO Child Growth Standards to facilitate a smooth transition at 5 years. They addressed the 
limitations of the 1977 NCHS curves, applying updated statistical methods (the Box-Cox power 
exponential method) and appropriate diagnostic tools for the selection of the best models.
15
  
The WHO standards and references demonstrate that healthy children and adolescents, regardless of 
their ancestries or ethnicities, who are raised in healthy environments, receive adequate health care and 
follow recommended feeding practices, have similar patterns of growth. This indicates that the same 
potential for growth in any country should be expected. It also implies that deviation from this pattern 
must be assumed to reflect adverse conditions, such as lack of breastfeeding, nutrient-poor or energy-
excessive foods, deficient health care services and/or poverty that requires correction. So, it seems that 
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the WHO 2006/2007 growth charts are a more adequate instrument to assess and monitor growth and 
nutritional status among Portuguese school-aged children and adolescents, as among other child and 
adolescent populations all over the world. 
Regardless of the charts, the cut-off values selected are arbitrary statistical cut-off values; they are not 
based on clinical research or health outcome risk. The 85
th
 and 95
th
 percentiles when applied to the 
CDC charts, are relative to an entire national population not selected for any health or growth 
characteristics; the 97
th
 and 99
th
 percentiles when applied to the WHO charts, are relative to a highly 
selected international population of children expected to be healthy. The IOTF/Cole cut-off points are 
based on international data and linked to the widely accepted cut-off points for adult overweight and 
obesity. Cole’s approach avoids some of the usual arbitrariness of choosing reference data and cut-off 
values and seems to be more acceptable for international use; however, some important questions 
remain unanswered. Are the health consequences for children above those cut-off points equal to those 
for adults? How accurately do they identify children and adolescents at increased risk of morbidity 
related to overweight and obesity? 
In the late 1980s, in the attempt to determine early life risk factors for adult ill-health, emerged a new 
research area known as the “developmental origins of adult health and disease”. In 1992, Hales and 
Barker
22
 published an article linking fetal malnutrition and consequently low birth weight with 
reduced pancreatic beta cell mass and islet function. These characteristics reflect human 
developmental plasticity, which increase the immediate survival capacity of the neonate after poor 
nutritional experience in utero. These traits track on into adulthood and induce an increased risk of 
developing type 2 diabetes mellitus, especially if BMI increases. Other organs may equally alter in 
response to fetal malnutrition. These early physiological/adaptive alterations determine susceptibility 
to insulin resistance or other pathophysiological processes, and additional factors such as obesity, 
aging or physical activity play a role in deciding the time of onset and severity of diabetes as well as of 
other degenerative diseases. As a matter of fact, the “thrifty phenotype hypothesis” proposed by Hales 
and Barker states that the risk of degenerative diseases such as hypertension, stroke, cardiovascular 
disease and type 2 diabetes mellitus is associated with growth patterns during early life. 
The “thrifty phenotype” reflects a continuum of variability and developmental plasticity relates to the 
entire population and not only to those considered as outliers. In fact, even within the range of normal 
birth weight, fetal as well as post-natal weight gain has a dose-response association with later disease 
risk. Two fundamental components of phenotype must be considered: the “metabolic capacity” and 
the “metabolic load”. Metabolic capacity refers to a variety of aspects related to organ structure and 
function that emerge during fetal life and infancy, when the growth process is dominated by 
hyperplasia (e.g. number of pancreatic beta cell mass, capacity to secrete insulin, lung airway function, 
nephron number or liver volume). Metabolic load refers to the burden imposed on the homeostatic 
metabolic capacity of the organism by the tissue masses that emerge during the hypertrophic period of 
growth (e.g. obesity, dietary glycaemic load and sedentary behaviours increase metabolic load). 
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Decreasing metabolic capacity and increasing metabolic load each contribute to elevated metabolic 
risk. Interactive effects of birth weight and weight gain during infancy, childhood and adolescence 
have proven to influence the risk of developing hypertension, insulin resistance, glucose 
intolerance/diabetes, dyslipidaemia (hypercholesterolemia and/or hypertriglyceridemia), chronic 
inflammation (chronic high levels of C-reactive protein) and cardiovascular disease later in adult life.
23 
As a matter of fact, it is largely recognized that human growth is sensitive to a wide range of 
environmental factors in early life. In a first instance, this wide range of factors exerts their effects 
mediated by maternal phenotype. The fetus relies completely on the maternal metabolism, even to 
experience (indirectly) the ecological environment. So, it adapts to the maternal metabolism and 
phenotype, and thus, alters its investment strategy according to its early experience, during a critical 
window of plasticity mostly restricted to pregnancy and lactation. The consequences of those 
alterations in investment strategy track on into adulthood and correspond to the wide range of 
variability in offspring metabolic capacity. Afterwards, the offspring is confronted directly to the 
environment and consequently is subjected to new external stimuli that may increase its metabolic 
load and the risk of developing a metabolic disease later in life. 
Growth patterns in childhood and adolescence for the Portuguese population under study don’t differ 
substantially between the WHO and the CDC growth references. As seen in Figures 5 and 6, the two 
drafts are quite parallel and the average BMI-for-age Z-scores of Oporto’s population sample included 
in the WHO references are persistently above the CDC median. This difference between WHO and 
CDC growth charts remains quite the same throughout childhood being, however, less pronounced at 
older ages. In fact, there is a tendency of overlapping of the drafts as the population under study gets 
older. This pattern of growth is the same when girls and boys are assessed separately. Moreover, this 
study also shows that the CDC growth references tend to classify Oporto’s population sample of 
children and adolescents aged 6-16 years as having a normal, expected BMI-for-age (in Fig. 7A, the 
regression line based on the CDC growth references follows almost perfectly the mean BMI-for-age 
Z-score 0SD). On the other hand, the same population sample based on the WHO growth references 
appears to be heavy (in Fig. 7B, the regression line based on the WHO growth references traces 
parallel and persistently above the mean BMI-for-age Z-score 0SD). Therefore, it seems that the 
probability of missing the identification of overweight and obese children and adolescents is higher 
with the CDC than with the WHO references. 
In fact, the WHO charts, considering the methodological approach used for their conception, represent 
an ideal, healthy population of children and adolescents with an ideal, healthy pattern of growth, i.e. 
without decreasing metabolic capacity and/or increasing metabolic load and consequently without 
increased risk of a metabolic disease. The WHO took particular care in selecting strict inclusion and 
exclusion criteria, choosing households with socioeconomic status that did not constrain the growth of 
the child and non-smoking, healthy mothers willing to follow international feeding recommendations.  
Once again, any deviation from this pattern most probably reflects inadequate growth and implies 
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adverse health conditions that need correction and in this way the WHO 2006/2007 growth charts 
compared to the CDC 2000 growth curves and to the IOTF/Cole references, seem to be more accurate 
in identifying overweight and obese children/adolescents at increased risk of morbidity and mortality 
later in adult life as well as during childhood and adolescence. 
By taking into account the deductions referred previously, is it possible to state that the use of growth 
charts has predictive implications later in adult life? 
A large body of scientific evidence on the health impact of childhood obesity has been collected over 
the last few years. Obesity in childhood is related to adverse outcomes: hypertension, dyslipidaemia, 
glucose intolerance/type 2 diabetes mellitus constitute a clustering of cardiovascular risk factors, 
known as “the metabolic syndrome”. This syndrome has been identified in children as young as 5 
years old. It is now well established that childhood obesity has adverse effects on the cardiovascular 
system of young obese children which are similar to those well known in adults.  
The persistence or relative stability of overweight/obesity and their related risk factors and health 
conditions over the lifespan is now generally accepted. The risk of overweight children to become 
overweight adults is twice as high compared with normal-weight children. For the obese youth the risk 
is even higher.
24
 33% of obese children less than 6 years old, approximately 50% of obese children 
between 6 and 11 years old and 80% of obese adolescents remain obese later in life.
25
 This concept of 
persistence of obesity is referred to as “tracking of childhood obesity into adulthood” and enables the 
acceptance of the predictability of future values by early measurements. The persistence of weight 
status and the importance of the child’s weight status increase with age, becoming the most important 
predictor after the age of 9. The persistence of childhood obesity into adulthood is intimately related to 
the age of the child/adolescent, to the severity of the childhood obesity and to the presence of parental 
obesity. This induces the idea of a genetic predisposition to obesity as well as a gene-environment 
interaction.
26 
Looking at the developmental aspects of growth and body weight increases our understanding of how 
a child accumulates excess weight. Adipose tissue may be found in the fetus after the 14
th
 week of 
gestation. By birth adipose tissue amounts to about 13% of the new-born’s body mass, doubling to 
around 28% by the end of the first year for a normal-weight infant.
27
 This period is referred to by 
Stratz as the “first filling period”. It is followed by a fall in the fat proportion of body mass over the 
next 4-6 years. A “second filling period” frequently associated with the “adiposity rebound” occurs 
just before puberty. During the later adolescence or puberty happens the “final filling period”. These 
are 3 critical periods characterized by fat accumulation where children or adolescents, when exposed 
to noxious stimuli, may be more prone to develop overweight and obesity.
25
  
Some notions, such as “filling periods” and “early adiposity rebound” are fundamental to our 
understanding of childhood obesity and its associated co-morbidities. The minimum value of BMI, 
just before the second filling period of fat accumulation, is known as the “adiposity rebound” 
(Rolland-Cachera). It reflects an accelerated weight gain due to body fat deposition rather than a 
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slower height acquisition. “Early adiposity rebound” is typically noted before age 5 years, “late 
adiposity rebound” occurs after age 7. Several studies demonstrated a strong relationship between 
timing of adiposity rebound and higher levels of BMI, impaired glucose tolerance/diabetes and 
elevated blood pressure in later childhood and adulthood.
28
 However, adiposity rebound isn’t a useful 
clinical tool to assess risk of future fatness given the time frame required for measurement (assessing 
adiposity rebound requires a minimum of 3 successive BMI measurements and it can only really be 
detected once that point has passed). In Figures 8 and 9, three phenomenons are observed. There is a 
first upward slope in mean BMI-for-age Z-score that initiates at age 7, regardless of gender and of 
growth references. A second upward slope in mean BMI-for-age Z-score initiates a few years later. 
This slope, however, is more precocious as well as more pronounced for girls (Fig. 8) than for boys 
(Fig. 9), independently of the growth references considered. Finally, the deviation from the mean 
BMI-for-age Z-score 0SD, regardless of gender, is more marked based on the WHO (Fig. 8B and 9B) 
than based on the CDC growth references (Fig. 8A and 9A). It seems that using the polynomial 
regression model to analyse Oporto’s population sample shows the last 2 of the 3 critical periods of fat 
accumulation.  
Several recent studies have demonstrated that elevated BMI in childhood and adolescence has an 
intimate relationship with degenerative diseases later in adulthood. Baker et al.
29 
found that higher 
childhood BMI values elevated the risk of having a coronary heart disease (CHD) event in young 
adulthood. Each 1-unit increase in BMI Z-score, at every age from 7-13 years in boys and from 10-13 
years in girls, significantly increased the risk of an event. This association proved to be stronger with 
increasing age during this period of childhood. Tirosh et al.
30
, on the other hand, found that elevated 
BMI in adolescence (from 17 years of age onwards) had distinctive relationships with type 2 diabetes 
mellitus and CHD in young adulthood. Diabetes was influenced mainly by recent BMI and weight 
gain, whereas for CHD both elevated BMI in adolescence and recent BMI were independent risk 
factors. Tirosh concluded that these distinctive associations with diabetes and CHD in young 
adulthood were most probably due to the fact that diabetes represents a more functional patho-
mechanism than CHD, which relies more on anatomical changes (i.e. atherosclerosis).  
These conclusions were deduced with BMI values well within the “normal/healthy” range established 
by the CDC as well as by the WHO. Currently, children and adolescents are typically classified as 
being at risk of degenerative diseases only if their BMI values are above cut-offs points such as the 
85
th
 percentile on growth charts. The results of recent studies do not support this approach. Baker 
identified a linearity of association between childhood BMI and adult risk of CHD. Even small 
amounts of weight gain increased the risk of a CHD event. Tirosh equally found that the distinctive 
relationships with type 2 diabetes mellitus and CHD in young adulthood already exist within the 
“normal/healthy” range of BMI values. 
Childhood and adolescence BMI are independent predictors of CHS in young adulthood (even BMI 
values within the normal, healthy range defined by the CDC and the WHO), suggesting that body 
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mass has long-term consequences. Although, child and adolescent BMI are also predictors of the risk 
of developing type 2 diabetes mellitus, the risk seems to be dependent of that predicted by BMI values 
in adulthood.   
These conclusions highlight the clinical importance of considering BMI history and consequently of 
monitoring BMI evolution during childhood and adolescence when assessing the risk of CHD and 
diabetes in young adults, mostly young overweight and obese adults. They also highlight the 
importance of the role of increasing BMI at different ages in the pathogenesis of different diseases. As 
a matter of fact, early pubertal and early adiposity rebound in childhood must probably are implicated 
in the development of obesity and its related comorbidities. Finally, these conclusions highlight the 
urgent need to accurately define what really constitutes a “normal” or “healthy” BMI value in 
childhood and adolescence. 
 
Conclusion 
Despite the limitations of the current study, it seems quite clear that the WHO growth standards and 
references represent a more adequate and accurate tool to assess and monitor childhood and 
adolescence health and nutritional status compared to the CDC growth curves. The WHO charts are 
more effective in correctly diagnosing individuals at increased risk of degenerative diseases such as 
coronary heart disease or type 2 diabetes mellitus later in life. The early identification of those 
individuals enables health care providers to initiate early interventions to prevent overweight and 
obesity as well as future health complications related to overweight/obesity.  
Despite the fact that the IOTF/Cole references, compared to other cut-off values, seem more 
appropriate to define overweight and obesity in childhood and adolescence and more acceptable for 
international comparisons, they are not conceived for health and growth monitoring of individual 
children and adolescents. Therefore, new definitions are needed to address accurate physical 
evaluations of children and adolescents. Moreover, increasing scientific evidence suggests that the 
range of normal, healthy BMI values isn’t the same regardless of the population studied as well as the 
health consequences of overweight and obesity aren’t the same regardless of ethnicity. So, more 
clinical-based research is needed to establish which childhood and adolescence definitions of 
overweight and obesity actually relate to adverse health outcomes later in adulthood. 
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